133 related articles for article (PubMed ID: 2656985)
1. Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I.
Mishima M; Okada S; Wakita Y; Nakano M
J Pharmacobiodyn; 1989 Jan; 12(1):31-6. PubMed ID: 2656985
[TBL] [Abstract][Full Text] [Related]
2. Studies on the promoting effects of medium chain fatty acid salts on the nasal absorption of insulin in rats.
Mishima M; Wakita Y; Nakano M
J Pharmacobiodyn; 1987 Nov; 10(11):624-31. PubMed ID: 3328778
[TBL] [Abstract][Full Text] [Related]
3. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133
[TBL] [Abstract][Full Text] [Related]
4. Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.
Zhang Y; Jiang XG; Yao J
Acta Pharmacol Sin; 2001 Nov; 22(11):1051-6. PubMed ID: 11749800
[TBL] [Abstract][Full Text] [Related]
5. Promotion of rectal absorption of sodium ampicillin by disodium glycyrrhetinic acid 3 beta-O-monohemiphthalate in rats.
Mishima M; Nagatomi A; Yamakita T; Miura Y; Tsuzuki O
Biol Pharm Bull; 1995 Apr; 18(4):566-70. PubMed ID: 7655429
[TBL] [Abstract][Full Text] [Related]
6. Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. II. In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa.
Tengamnuay P; Mitra AK
Pharm Res; 1990 Apr; 7(4):370-5. PubMed ID: 2194199
[TBL] [Abstract][Full Text] [Related]
7. Enhanced rectal and nasal absorption of human epidermal growth factor by combined use of the absorption promoter and the synthetic polymer in rats.
Murakami T; Kishimoto M; Kawakita H; Kisaki M; Kojima Y; Higashi Y; Amagase H; Fuwa T; Yata N
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():125-31. PubMed ID: 1820866
[TBL] [Abstract][Full Text] [Related]
8. Isolation, characterization and study of enhancing effects on nasal absorption of insulin in rat of the total saponin from Acanthophyllum squarrosum.
Sajadi Tabassi SA; Hosseinzadeh H; Ramezani M; Moghimipour E; Mohajeri SA
Curr Drug Deliv; 2006 Oct; 3(4):399-404. PubMed ID: 17076642
[TBL] [Abstract][Full Text] [Related]
9. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
[TBL] [Abstract][Full Text] [Related]
10. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
[TBL] [Abstract][Full Text] [Related]
11. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter.
Aungst BJ; Rogers NJ; Shefter E
J Pharmacol Exp Ther; 1988 Jan; 244(1):23-7. PubMed ID: 3275772
[TBL] [Abstract][Full Text] [Related]
12. Nasal absorption in the rat. III. Effect of lysophospholipids on insulin absorption and nasal histology.
Chandler SG; Thomas NW; Illum L
Pharm Res; 1994 Nov; 11(11):1623-30. PubMed ID: 7870681
[TBL] [Abstract][Full Text] [Related]
13. Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats.
Deurloo MJ; Hermens WA; Romeyn SG; Verhoef JC; Merkus FW
Pharm Res; 1989 Oct; 6(10):853-6. PubMed ID: 2692018
[TBL] [Abstract][Full Text] [Related]
14. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep.
Longenecker JP; Moses AC; Flier JS; Silver RD; Carey MC; Dubovi EJ
J Pharm Sci; 1987 May; 76(5):351-5. PubMed ID: 3309255
[TBL] [Abstract][Full Text] [Related]
15. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
[TBL] [Abstract][Full Text] [Related]
16. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
[TBL] [Abstract][Full Text] [Related]
17. Nasal absorption of insulin in dogs.
Harai S; Ikenaga T; Matsuzawa T
Diabetes; 1978 Mar; 27(3):296-9. PubMed ID: 25215
[TBL] [Abstract][Full Text] [Related]
18. Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.
Ahsan F; Arnold JJ; Meezan E; Pillion DJ
Pharm Res; 2001 May; 18(5):608-14. PubMed ID: 11465415
[TBL] [Abstract][Full Text] [Related]
19. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
du Plessis LH; Kotzé AF; Junginger HE
Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
[TBL] [Abstract][Full Text] [Related]
20. [Functional and pathological study of intranasal absorption of insulin aided by azone].
Hou T; Xin W; Dong Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Aug; 37(4):271-3. PubMed ID: 12772412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
